Exclusion Criteria:~Core Study~* Females who are breastfeeding or pregnant at Screening or Baseline. Females of
child-bearing potential must use a highly effective method of contraception throughout the entire study period
and for 28 days after study drug discontinuation~* Any condition that may be contributing to cognitive
impairment above and beyond that caused by the participant's AD~* Participants with a history of seizures
within 5 years of Screening~* History of transient ischemic attacks or stroke within 12 months of Screening~*
Psychiatric diagnosis or symptoms (example, hallucinations, major depression, delusions etc.)~* Suicidal
ideation or any suicidal behavior within 6 months before Screening or has been hospitalized or treated for
suicidal behavior in the past 5 years~* Have any contraindications to magnetic resonance imaging (MRI) scanning
or~ 1. Have lesions that could indicate a dementia diagnosis other than AD on brain MRI~ 2. Exhibit other
significant pathological findings on brain MRI.~* Participants who have a history of moderate to severe hepatic
impairment (example, Child-Pugh Class B or C)~* Results of laboratory tests conducted during Screening that are
outside the following limits:~ 1. Absolute lymphocyte count below the lower limit of normal (LLN)~ 2. Thyroid
stimulating hormone above normal range~ 3. Abnormally low Vitamin B12 levels~* Participants at increased risk
of infection~* Have received any live vaccine/live attenuated vaccine in the 3 months before randomization~*
Any chronic inflammatory disease that is not adequately controlled or that requires systemic immunosuppressive
or immunomodulatory therapy~* Any other clinically significant abnormalities~* Severe visual or hearing
impairment~* A prolonged corrected QT (QTc) interval (QT interval with Fridericia's correction \[QTcF\] greater
than 450 milliseconds \[ms\])~* Malignant neoplasms within 5 years of Screening~* Known or suspected history of
drug or alcohol abuse~* Taking prohibited medications, which must be reviewed with the Investigator~* Have
participated in a recent clinical study~Note: Other protocol-defined Inclusion/Exclusion Criteria may apply.
